HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 131 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,976,000 | -67.3% | 200,000 | -60.1% | 0.25% | -55.2% |
| Q3 2016 | $6,051,000 | -26.1% | 500,904 | -47.2% | 0.56% | -43.5% |
| Q2 2016 | $8,188,000 | -19.4% | 948,803 | -11.6% | 0.99% | -28.2% |
| Q1 2016 | $10,163,000 | -46.7% | 1,073,154 | -2.4% | 1.38% | -25.3% |
| Q4 2015 | $19,063,000 | +33.7% | 1,100,000 | +3.6% | 1.85% | +48.6% |
| Q3 2015 | $14,257,000 | -62.8% | 1,061,547 | -37.5% | 1.24% | -54.3% |
| Q2 2015 | $38,329,000 | +53.4% | 1,697,504 | -3.0% | 2.72% | +36.7% |
| Q1 2015 | $24,986,000 | -4.1% | 1,749,691 | -35.2% | 1.99% | +11.4% |
| Q4 2014 | $26,055,000 | +91.0% | 2,700,000 | +80.1% | 1.79% | +90.0% |
| Q3 2014 | $13,643,000 | +2.3% | 1,499,214 | +11.1% | 0.94% | +34.2% |
| Q2 2014 | $13,338,000 | – | 1,350,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $51,293,000 | 7.24% |
| First Light Asset Management, LLC | 2,050,273 | $93,103,000 | 5.59% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,350,870 | $61,343,000 | 5.06% |
| SNYDER CAPITAL MANAGEMENT L P | 3,176,404 | $144,241,000 | 4.04% |
| DOHENY ASSET MANAGEMENT /CA | 91,930 | $4,175,000 | 2.69% |
| Redwood Investments, LLC | 538,656 | $24,460,000 | 1.97% |
| HighMark Wealth Management LLC | 53,457 | $2,427,000 | 1.78% |
| Taylor Wealth Management Partners | 85,409 | $3,878,000 | 1.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 66,673 | $3,028,000 | 1.35% |
| Granite Investment Partners, LLC | 919,029 | $41,733,000 | 1.29% |